histiocytosis

(redirected from sinus histiocytosis)
Also found in: Dictionary, Medical, Encyclopedia.
Related to sinus histiocytosis: sinus histiocytosis with massive lymphadenopathy
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to histiocytosis

a blood disease characterized by an abnormal multiplication of macrophages

References in periodicals archive ?
Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): Imaging manifestations in the head and neck.
Immunologic abnormalities and their significance in sinus histiocytosis with massive lymphadenopathy.
As far as we could establish from a PubMed search, no other case of sinus histiocytosis and liver cirrhosis has been reported.
Gaitonde, "Multifocal, extranodal sinus histiocytosis with massive lymphadenopathy: an overview," Archives of Pathology and Laboratory Medicine, vol.
Sinus histiocytosis with massive lymphadenopathy: A newly recognized benign clinicopathological entity.
Rosai J, Dorfman RE Sinus histiocytosis with massive lymphadenopathy.
Sinus histiocytosis with massive lymphadenopathy (SHML) was first described by Rosai and Dorfman in 1969 as a disease characterized by nodal histiocytic infiltration (2).
Sinus histiocytosis of lymph nodes after hip replacement.
sup][11] Germline mutations in SLC29A3 have been reported in rare patients with a wide range of overlapping clinical features and inherited disorders including H syndrome, pigmented hypertrichosis with insulin-dependent diabetes (PHID), Faisalabad histiocytosis, sinus histiocytosis with massive lymphadenopathy, dysosteosclerosis (DSS) and monogenic autoinflammatory syndrome.
Sections from lymphnodes show features of sinus histiocytosis.
In lymph nodes, the cells are often distributed in a sinus pattern, and can be overlooked as conventional, nonneoplastic sinus histiocytosis.
There was only sinus histiocytosis of right and left lymph node chain but no regional metastasis.
The term sinus histiocytosis with massive lymphadenopathy (SHML) was introduced by doctors Rosai and Dorfman in 1969 as a well-defined clinicopathologic entity that is now widely known as Rosai-Dorfman disease.